Literature DB >> 31784425

Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.

Karen Sachs1,2, Aaron L Sarver3, Klara E Noble-Orcutt1,3, Rebecca S LaRue1,3, Marie Lue Antony1,3, Daniel Chang1,3, Yoonkyu Lee1,3, Connor M Navis1, Alexandria L Hillesheim1, Ian R Nykaza1, Ngoc A Ha1, Conner J Hansen1, Fatma K Karadag1, Rachel J Bergerson4, Michael R Verneris4, Matthew M Meredith5, Matthew L Schomaker5, Michael A Linden6, Chad L Myers7, David A Largaespada3,4, Zohar Sachs8,3.   

Abstract

Standard chemotherapy for acute myeloid leukemia (AML) targets proliferative cells and efficiently induces complete remission; however, many patients relapse and die of their disease. Relapse is caused by leukemia stem cells (LSC), the cells with self-renewal capacity. Self-renewal and proliferation are separate functions in normal hematopoietic stem cells (HSC) in steady-state conditions. If these functions are also separate functions in LSCs, then antiproliferative therapies may fail to target self-renewal, allowing for relapse. We investigated whether proliferation and self-renewal are separate functions in LSCs as they often are in HSCs. Distinct transcriptional profiles within LSCs of Mll-AF9/NRASG12V murine AML were identified using single-cell RNA sequencing. Single-cell qPCR revealed that these genes were also differentially expressed in primary human LSCs and normal human HSPCs. A smaller subset of these genes was upregulated in LSCs relative to HSPCs; this subset of genes constitutes "LSC-specific" genes in human AML. To assess the differences between these profiles, we identified cell surface markers, CD69 and CD36, whose genes were differentially expressed between these profiles. In vivo mouse reconstitution assays resealed that only CD69High LSCs were capable of self-renewal and were poorly proliferative. In contrast, CD36High LSCs were unable to transplant leukemia but were highly proliferative. These data demonstrate that the transcriptional foundations of self-renewal and proliferation are distinct in LSCs as they often are in normal stem cells and suggest that therapeutic strategies that target self-renewal, in addition to proliferation, are critical to prevent relapse and improve survival in AML. SIGNIFICANCE: These findings define and functionally validate a self-renewal gene profile of leukemia stem cells at the single-cell level and demonstrate that self-renewal and proliferation are distinct in AML. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/80/3/458/F1.large.jpg. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31784425      PMCID: PMC7002190          DOI: 10.1158/0008-5472.CAN-18-2932

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  51 in total

1.  Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia.

Authors:  Amy L Paguirigan; Jordan Smith; Soheil Meshinchi; Martin Carroll; Carlo Maley; Jerald P Radich
Journal:  Sci Transl Med       Date:  2015-04-01       Impact factor: 17.956

2.  Calcium-binding protein S100A4 confers mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis.

Authors:  Hong Xia; Adam Gilbertsen; Jeremy Herrera; Emilian Racila; Karen Smith; Mark Peterson; Timothy Griffin; Alexey Benyumov; Libang Yang; Peter B Bitterman; Craig A Henke
Journal:  J Clin Invest       Date:  2017-05-22       Impact factor: 14.808

3.  Repressible transgenic model of NRAS oncogene-driven mast cell disease in the mouse.

Authors:  Stephen M Wiesner; Jamie M Jones; Diane E Hasz; David A Largaespada
Journal:  Blood       Date:  2005-04-14       Impact factor: 22.113

4.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.

Authors:  D Bonnet; J E Dick
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

5.  DNMT3A Haploinsufficiency Transforms FLT3ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia.

Authors:  Sara E Meyer; Tingting Qin; David E Muench; Kohei Masuda; Meenakshi Venkatasubramanian; Emily Orr; Lauren Suarez; Steven D Gore; Ruud Delwel; Elisabeth Paietta; Martin S Tallman; Hugo Fernandez; Ari Melnick; Michelle M Le Beau; Scott Kogan; Nathan Salomonis; Maria E Figueroa; H Leighton Grimes
Journal:  Cancer Discov       Date:  2016-03-25       Impact factor: 39.397

6.  Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells.

Authors:  H Gal; N Amariglio; L Trakhtenbrot; J Jacob-Hirsh; O Margalit; A Avigdor; A Nagler; S Tavor; L Ein-Dor; T Lapidot; E Domany; G Rechavi; D Givol
Journal:  Leukemia       Date:  2006-10-12       Impact factor: 11.528

7.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Authors:  Andrei V Krivtsov; David Twomey; Zhaohui Feng; Matthew C Stubbs; Yingzi Wang; Joerg Faber; Jason E Levine; Jing Wang; William C Hahn; D Gary Gilliland; Todd R Golub; Scott A Armstrong
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

8.  Overcoming mutational complexity in acute myeloid leukemia by inhibition of critical pathways.

Authors:  Yoriko Saito; Yoshiki Mochizuki; Ikuko Ogahara; Takashi Watanabe; Leah Hogdal; Shinsuke Takagi; Kaori Sato; Akiko Kaneko; Hiroshi Kajita; Naoyuki Uchida; Takehiro Fukami; Leonard D Shultz; Shuichi Taniguchi; Osamu Ohara; Anthony G Letai; Fumihiko Ishikawa
Journal:  Sci Transl Med       Date:  2017-10-25       Impact factor: 17.956

9.  Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche.

Authors:  Haobin Ye; Biniam Adane; Nabilah Khan; Timothy Sullivan; Mohammad Minhajuddin; Maura Gasparetto; Brett Stevens; Shanshan Pei; Marlene Balys; John M Ashton; Dwight J Klemm; Carolien M Woolthuis; Alec W Stranahan; Christopher Y Park; Craig T Jordan
Journal:  Cell Stem Cell       Date:  2016-06-30       Impact factor: 24.633

10.  A single-cell resolution map of mouse hematopoietic stem and progenitor cell differentiation.

Authors:  Sonia Nestorowa; Fiona K Hamey; Blanca Pijuan Sala; Evangelia Diamanti; Mairi Shepherd; Elisa Laurenti; Nicola K Wilson; David G Kent; Berthold Göttgens
Journal:  Blood       Date:  2016-06-30       Impact factor: 22.113

View more
  11 in total

Review 1.  CD36: an emerging therapeutic target for cancer and its molecular mechanisms.

Authors:  Chengwei Ruan; Yankai Meng; Hu Song
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-27       Impact factor: 4.553

Review 2.  Leukemic stem cell signatures in Acute myeloid leukemia- targeting the Guardians with novel approaches.

Authors:  Deepshi Thakral; Ritu Gupta; Aafreen Khan
Journal:  Stem Cell Rev Rep       Date:  2022-03-28       Impact factor: 6.692

Review 3.  Single-Cell Sequencing: Ariadne's Thread in the Maze of Acute Myeloid Leukemia.

Authors:  Immacolata Redavid; Maria Rosa Conserva; Luisa Anelli; Antonella Zagaria; Giorgina Specchia; Pellegrino Musto; Francesco Albano
Journal:  Diagnostics (Basel)       Date:  2022-04-15

Review 4.  Acute Myeloid Leukemia Stem Cells: The Challenges of Phenotypic Heterogeneity.

Authors:  Marlon Arnone; Martina Konantz; Pauline Hanns; Anna M Paczulla Stanger; Sarah Bertels; Parimala Sonika Godavarthy; Maximilian Christopeit; Claudia Lengerke
Journal:  Cancers (Basel)       Date:  2020-12-12       Impact factor: 6.639

Review 5.  Single-cell RNA sequencing to track novel perspectives in HSC heterogeneity.

Authors:  Pan Zhang; Xiang Li; Chengwei Pan; Xinmin Zheng; Bohan Hu; Ruiheng Xie; Jialu Hu; Xuequn Shang; Hui Yang
Journal:  Stem Cell Res Ther       Date:  2022-01-29       Impact factor: 6.832

Review 6.  Isolation, Maintenance and Expansion of Adult Hematopoietic Stem/Progenitor Cells and Leukemic Stem Cells.

Authors:  Isabella Maria Mayer; Andrea Hoelbl-Kovacic; Veronika Sexl; Eszter Doma
Journal:  Cancers (Basel)       Date:  2022-03-28       Impact factor: 6.639

7.  Deciphering the Non-Coding RNA Landscape of Pediatric Acute Myeloid Leukemia.

Authors:  Jolien Vanhooren; Laurens Van Camp; Barbara Depreter; Martijn de Jong; Anne Uyttebroeck; An Van Damme; Laurence Dedeken; Marie-Françoise Dresse; Jutte van der Werff Ten Bosch; Mattias Hofmans; Jan Philippé; Barbara De Moerloose; Tim Lammens
Journal:  Cancers (Basel)       Date:  2022-04-22       Impact factor: 6.639

Review 8.  The contribution of single-cell analysis of acute leukemia in the therapeutic strategy.

Authors:  Lamia Madaci; Julien Colle; Geoffroy Venton; Laure Farnault; Béatrice Loriod; Régis Costello
Journal:  Biomark Res       Date:  2021-06-27

9.  Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeq.

Authors:  Gerard Lozanski; James S Blachly; Caner Saygin; Eileen Hu; Pu Zhang; Steven Sher; Arletta Lozanski; Tzyy-Jye Doong; Deedra Nicolet; Shelley Orwick; Jadwiga Labanowska; Jordan N Skinner; Casey Cempre; Tierney Kauffman; Virginia M Goettl; Nyla A Heerema; Lynne Abruzzo; Cecelia Miller; Rosa Lapalombella; Gregory Behbehani; Alice S Mims; Karilyn Larkin; Nicole Grieselhuber; Alison Walker; Bhavana Bhatnagar; Clara D Bloomfield; John C Byrd
Journal:  Leukemia       Date:  2021-05-21       Impact factor: 11.528

10.  EGR1 dysregulation defines an inflammatory and leukemic program in cell trajectory of human-aged hematopoietic stem cells (HSC).

Authors:  Christophe Desterke; Annelise Bennaceur-Griscelli; Ali G Turhan
Journal:  Stem Cell Res Ther       Date:  2021-07-22       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.